Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4107 results

Sort By:

A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders

Study ID: NCT06904027
Start Date: 2025-07
End Date: 2031-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Glycerol phenylbutyrate Oral Liquid

Sponsor

Tongji Hospital

Source: clinicaltrials.gov

Share:
Add to list

Primary Preventive Ventricular Tachycardia Ablation in High-Risk Patients Who Receive a Prophylactic Implantable Cardioverter Defibrillator

Study ID: NCT06543173
Start Date: 2025-07-01
End Date: 2030-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

62

Intervention / Treatment

Prophylactic Catheter-based VT Ablation

Sponsor

University of Rochester

Source: clinicaltrials.gov

Share:
Add to list

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

Study ID: NCT06309173
Start Date: 2025-07
End Date: 2028-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment
Sponsor

University Hospital, Basel, Switzerland

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma

Study ID: NCT06903273
Start Date: 2025-07-01
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Tiskelizumab

Sponsor

National Cheng-Kung University Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z

Study ID: NCT06929260
Start Date: 2025-04-22
End Date: 2026-01-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Ceralasertib

Drug X

Friend and

Second of

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy

Study ID: NCT06702527
Start Date: 2025-05-01
End Date: 2026-09-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Mitral transcatheter edge-to-edge repair

Sponsor

Institute for Pharmacology and Preventive Medicine

Source: clinicaltrials.gov

Share:
Add to list

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

Study ID: NCT06898060
Start Date: 2025-06
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

282

Intervention / Treatment

QLG2128

Teriparatide Injection

Sponsor

Qilu Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Online Patient Navigation Program for Patients with Breast Cancer

Study ID: NCT06597773
Start Date: 2025-07-01
End Date: 2026-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Online patient navigation and supportive care referrals

In-person patient navigation and supportive care referrals

Sponsor

Doctors and researchers in the fight against breast cancer

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

Study ID: NCT06782373
Start Date: 2025-05
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Pacritinib

Placebo

Sponsor

Swedish Orphan Biovitrum

Source: clinicaltrials.gov

Share:
Add to list

UNCPM 22322 - Adaption of the Transition of Care Model for Post-Discharge HIV-NCD Care in Lilongwe, Malawi - MLATHO

Study ID: NCT06931431
Start Date: 2025-05
End Date: 2027-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Transition of Care Model (TCM)

Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list